文献速递免疫规划传染病防控与疫情报告

巴西南部乙型流感病毒的分子流行病学及其对免疫策略的启示

Molecular epidemiology of influenza B virus and implications in immunization strategy, Southern Brazil.
PubMed 文献 · Vaccine · 2017-11-23

研究分析了2013至2016年巴西巴拉那州流行病学监测服务采集的临床样本中的乙型流感(Flu B)感染,在379份乙型流感阳性样本中370份(98%)被鉴定为B/Yam或B/Vic谱系,两谱系分别占47%和53%。2013年疫苗株与流行株不匹配,同时观察到大量严重急性呼吸道感染(SARI)病例;B/Vic谱系与更多SARI病例相关(62%),B/Yam与流感样疾病(ILI)相关(61%)。作者认为乙型流感谱系流行的不可预测性及不同谱系的流行病学差异直接影响疫苗接种策略。

要点

  • 370份(98%)乙型流感阳性样本被鉴定为B/Yam或B/Vic谱系,分别占47%和53%。
  • 2013年疫苗株与流行株不匹配,同时出现大量SARI病例。
  • B/Vic谱系与更多SARI病例相关(62%),B/Yam与ILI相关(61%)。

核心结论

  • 乙型流感谱系流行的不可预测性可在疫苗不匹配季节导致严重疾病大幅增加,B/Vic与B/Yam谱系在目标人群中的流行病学差异也可能与疾病负担增加相关,这些发现对疫苗接种策略有直接影响。
  • 作者认为需要在巴西开展进一步的乙型流感分子流行病学研究以印证这些初步结果。

研究设计与样本

  • 研究调查了2013至2016年巴西巴拉那州流行病学监测服务采集的临床样本中的乙型流感感染,采用qRT-PCR方法鉴定B/Yam和B/Vic谱系,并查阅了报告表。
  • 共评估379份乙型流感阳性样本,其中370份(98%)被鉴定为B/Yam或B/Vic谱系。

主要发现

  • B/Yam和B/Vic谱系共同循环,频率分别为47%和53%。
  • B/Yam在男女两性中感染情况相同,而B/Vic在女性中更常见(71%)。
  • B/Vic感染患者的中位年龄(23岁;11-35)低于B/Yam感染患者(32岁;12-50)。
  • B/Vic谱系与更多SARI病例相关(62%),B/Yam谱系与ILI相关(61%)。
  • 巴拉那州不同地区流行的毒株存在差异:B/Vic在西北部流行(67%),B/Yam在东南部流行(60%)。

局限性

  • 作者指出需要在巴西开展进一步的乙型流感分子流行病学研究以印证这些初步结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Epidemiological indicators have shown the substantial impact of influenza B (Flu B) on the development of severe acute respiratory infection (SARI) and on mortality rates. In Brazil, the trivalent vaccine, composed of only one Flu B lineage is available. We investigated Flu B infections in clinical samples collected by the epidemiological surveillance service of Paraná State, Brazil, from 2013 to 2016. The Flu B lineages Yamagata- (B/Yam) and Victoria-like (B/Vic) were identified using the qRT-PCR assay, and notification forms were reviewed. Among 379 Flu B positive samples evaluated, 370 (98%) were characterized as B/Yam or B/Vic lineages. Both co-circulated with a frequency of 47% and 53%, respectively. B/Yam infected equally both genders, while B/Vic was more frequent in females (71%). The median age of patients infected by B/Vic (23y; 11-35) was lower than that of patients infected by B/Yam (32y; 12-50). Mismatch between the vaccine and the circulating strain was observed in the 2013 season, with a high number of SARI cases. B/Vic lineage was associated with a larger number of SARI cases (62%), while B/Yam with influenza-like illness (ILI) (61%). Differences were observed in the strains circulating in separate regions of Paraná State. B/Vic was prevalent in the northwestern (67%) and B/Yam in the southeastern region (60%). The unpredictability of Flu B lineage circulation causes a substantial increase in severe disease during epidemics in a vaccine mismatch season. In addition, the differences in the epidemiological profile of the target population of Flu B infections in relation to other respiratory viruses, as well as among the B/Vic and B/Yam lineages may also be associated to an increase in disease burden. These findings have direct consequences on vaccination strategies. Therefore, further molecular epidemiology studies of Flu B in Brazil are required to corroborate these primary results.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Lapinscki B, Pereira LA, Nogueira MB, et al. Molecular epidemiology of influenza B virus and implications in immunization strategy, Southern Brazil. Vaccine. 2017. PMID: 29174679. doi:10.1016/j.vaccine.2017.11.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。